The move is just the latest development in a fierce ongoing debate about genetically altered flu viruses created in laboratories at Erasmus Medical Center in the Netherlands and at the University of Wisconsin-Madison.
The announcement came today at a scientific conference attended by about a thousand biodefense experts in Washington, D.C., that was organized by the American Society of Microbiology. One of the scientists who did the work, Ron Fouchier of Erasmus Medical Center, spoke at the conference and presented data suggesting that the mutant virus created in his lab was not as dangerous as has been presented in media reports.
